At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brains Company expands ...

A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...

Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...

Researchers have installed a high-resolution 3D spatial multi-omics system to study RNA regulation in intact brain tissue, ...

Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...

"Spatial transcriptomics opens entirely new pathways to gain crucial insight into the cellular function of organisms," said Steve Barnard, PhD, chief technology officer of Illumina. "Illumina spatial ...

The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling precision diagnostics, early disease detection, and targeted treatment ...